Skip to main content
Top
Published in: Journal of General Internal Medicine 7/2020

01-07-2020 | Viewpoint

Campaign Finance Reform as a Health Issue in the USA

Authors: Aditya K. Khetan, MD, Richard Josephson, MS, MD

Published in: Journal of General Internal Medicine | Issue 7/2020

Login to get access

Excerpt

Life expectancy in the USA peaked in 2014, with a lower life expectancy in 2018 than in 2014.1 No other high-income country has undergone a similar phenomenon since World War I, which points to the extraordinary circumstance that the USA finds itself in. While the rise of the opioid epidemic plays a role, it only explains about 20–25% of the increase in deaths. The remaining deaths stem from a combination of suicide, stroke, influenza, Alzheimer’s, and liver disease. Deaths from some of these diseases have been rising since around 2000; however, their effects on overall life expectancy were offset by decades of steadily declining mortality from cardiovascular diseases. This decline in cardiovascular mortality is now plateauing, and it is the sum total of these trends that have caused life expectancy to start declining in the past few years.2
Literature
1.
go back to reference Murphy SL, Xu J, Kochanek KD, Arias E. Mortality in the United States, 2018. Murphy SL, Xu J, Kochanek KD, Arias E. Mortality in the United States, 2018.
2.
go back to reference Case A, Deaton A. Mortality and morbidity in the 21st century. Brook Pap Econ Act. 2017;2017(1):397–476.CrossRef Case A, Deaton A. Mortality and morbidity in the 21st century. Brook Pap Econ Act. 2017;2017(1):397–476.CrossRef
3.
go back to reference Frieden TR. A framework for public health action: the health impact pyramid. Am J Public Health. 2010;100(4):590–5.CrossRef Frieden TR. A framework for public health action: the health impact pyramid. Am J Public Health. 2010;100(4):590–5.CrossRef
4.
go back to reference Chetty R, Stepner M, Abraham S, Lin S, Scuderi B, Turner N, et al. The association between income and life expectancy in the United States, 2001-2014. JAMA. 2016;315(16):1750–66.CrossRef Chetty R, Stepner M, Abraham S, Lin S, Scuderi B, Turner N, et al. The association between income and life expectancy in the United States, 2001-2014. JAMA. 2016;315(16):1750–66.CrossRef
5.
go back to reference Stand DW, Rising WIK. An overview of growing income inequalities in OECD countries: main findings. Divid We Stand Why Inequal Keeps Rising. 2011; Stand DW, Rising WIK. An overview of growing income inequalities in OECD countries: main findings. Divid We Stand Why Inequal Keeps Rising. 2011;
6.
go back to reference Pickett KE, Wilkinson RG. Income inequality and health: a causal review. Soc Sci Med. 2015;128:316–26.CrossRef Pickett KE, Wilkinson RG. Income inequality and health: a causal review. Soc Sci Med. 2015;128:316–26.CrossRef
7.
go back to reference Deaton A. Where in the world is the world heading? J Policy Model. 2017;39(4):603.CrossRef Deaton A. Where in the world is the world heading? J Policy Model. 2017;39(4):603.CrossRef
Metadata
Title
Campaign Finance Reform as a Health Issue in the USA
Authors
Aditya K. Khetan, MD
Richard Josephson, MS, MD
Publication date
01-07-2020
Publisher
Springer International Publishing
Published in
Journal of General Internal Medicine / Issue 7/2020
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-020-05828-9

Other articles of this Issue 7/2020

Journal of General Internal Medicine 7/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.